One pre-filled syringe contains 225 mg fremanezumab.
Fremanezumab is a humanised monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Solution for injection with a pH of 5.5 and an osmolality of 300-450 mOsm/kg.
Excipients/Inactive Ingredients: L-histidine, L-histidine hydrochloride monohydrate, Sucrose, Disodium ethylenediaminetetraacetic acid (EDTA) dihydrate, Polysorbate 80, Water for injections.